Some view the COVID-19 pandemic as a reputational turning point for pharma and an opportunity to solidify a more positive impact on society. Many pharmaceutical companies are furthering this goal by incorporating ESG into their operations.
A world facing climate change that threatens human health and long-term existence needs proven models that point the way to achieving a sustainable future. Israel, poised to join the inner circle of climate leaders, is a success story and a model for others to follow.